Search results
On doorstep of approval, Merck compares V116 pneumococcal vaccine to 1983 warhorse Pneumovax 23
FierceBiotech· 5 days agoFive months ago, Merck revealed data that indicate its next-generation pneumococcal vaccine offers more protection for older adults than Pfizer’s market dominator Prevnar ...
mRNA Is Promising A Breakthrough In Fighting Cancer
Benzinga via AOL· 5 days agoWhen it comes to cancer, there’s innovation both on the diagnostics and the treatment front thanks to messenger RNA, or mRNA, a genetic material we all...
Merck Announces Positive Data for V116, an Investigational, 21-Valent Pneumococcal Conjugate Vaccine...
Morningstar· 5 days agoThe trial evaluated the immunogenicity, tolerability and safety of V116 compared to PPSV23 (pneumococcal vaccine, polyvalent [23-valent]) in adults 50 years of age and older who had not previously ...
Moderna plants new solid tumor trials for cancer vaccine, weeds PD-1 work after review
FierceBiotech· 2 days agoModerna detailed plans for its individual neoantigen cancer vaccine in a first-quarter earnings...
New Immuno-Oncology Research Project in Partnership With Merck Starts at the BioMed X Institute in...
Digital Journal· 4 days agoHEIDELBERG, GERMANY / ACCESSWIRE / April 30, 2024 / BioMed X , a German biomedical research institute, announces the start of a new research project in partnership with Merck
Vanguard Health Care Fund's Strategic Moves in Q1 2024: A Focus on Pfizer Inc
GuruFocus.com via Yahoo Finance· 19 hours agoThe top holdings were 8.97% in Eli Lilly and Co (NYSE:LLY), 6.45% in UnitedHealth Group Inc...
The top pharmaceutical companies by R&D expenditure
Pharmaceutical Technology via Yahoo Finance· 2 days agoThis analysed R&D investments were in the form of strategic acquisitions to expand a company’s prowess in a particular area or by in-licensing drug...
40 future pharmacists receive doctoral hoods from ETSU College of Pharmacy
WJHL Tri-Cities via Yahoo News· 10 hours agoJOHNSON CITY, Tenn. (WJHL) – East Tennessee State University celebrated 40 of its Bill Gatton...
Hipgnosis song fund agrees $1.6bn takeover by founder’s private equity ally
The Telegraph via Yahoo Finance· 5 days agoHipgnosis has accepted a $1.6bn (£1.3bn) takeover offer from a US private equity company linked to...
Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
Zacks via Yahoo Finance· 2 days agoModerna did not record any grant and collaboration revenues during the quarter, compared to $34...